WCH — Wacker Chemie AG Balance Sheet
0.000.00%
- €3.44bn
- €4.28bn
- €5.72bn
- 65
- 74
- 31
- 59
Annual balance sheet for Wacker Chemie AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,367 | 1,667 | 1,787 | 1,412 | 1,260 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 770 | 966 | 1,147 | 985 | 949 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,579 | 3,848 | 4,660 | 3,902 | 4,055 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,504 | 2,606 | 2,961 | 3,261 | 3,597 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 6,951 | 8,134 | 9,401 | 8,854 | 9,410 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 826 | 1,712 | 1,927 | 1,763 | 1,523 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,325 | 5,116 | 4,538 | 4,438 | 4,741 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,625 | 3,019 | 4,864 | 4,417 | 4,669 |
Total Liabilities & Shareholders' Equity | 6,951 | 8,134 | 9,401 | 8,854 | 9,410 |
Total Common Shares Outstanding |